Sign in

Trial result ·

Neuronavigation-assisted versus conventional endoscopic endonasal transsphenoidal surgery for pituitary adenomas: a pilot randomized controlled trial.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This pilot trial looked at people with pituitary adenomas. Surgeons reached the tumor through the nose with an endoscope. One group had surgery helped by a navigation system. The other group had standard surgery without it. In all, 50 people took part, 25 in each group. Chance decided which group each person joined. The main aim was to see how much tumor was taken out.

What they found

The whole tumor was taken out more often with navigation. But this gap may have been due to chance. Tumor size, hormone activity and Knosp grade were tied to how much was removed. No giant tumor was fully removed. Median blood loss was 250 mL with navigation and 350 mL without. Surgery took about the same time in both groups.

What it means for patients

The authors say navigation did not clearly help remove more tumor. Still, results in most subgroups leaned toward navigation. They say the lower blood loss is only an idea to test further. They call for a larger trial at many centers.

Why it is not certain yet

This was a pilot trial with only 50 people. Its main job was to help plan a bigger trial. It took place at one university. The blood loss result still needs to be checked in new studies. The trial was registered after it had already started.

Source

Neuronavigation-assisted versus conventional endoscopic endonasal transsphenoidal surgery for pituitary adenomas: a pilot randomized controlled trial.

PubMed · PMID 43026363

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Pituitary tumours publications